Results 11 to 20 of about 12,889,276 (192)

Epidemiology of acute infections in people who inject drugs in Australia

open access: yesDrug and Alcohol Review, 2023
AbstractIssuesPeople who inject drugs are at risk of acute infections, such as skin and soft tissue infections, infective endocarditis, bone and joint infections and bloodstream infections. There has been an increase in these infections in people who inject drugs internationally over the past 10 years. However, the local data regarding acute infections
Lucy O. Attwood   +5 more
openaire   +3 more sources

Injecting equipment access and use in a sample of Australians who regularly inject drugs, 2022. [PDF]

open access: yes, 2023
People who inject drugs (PWID) have an increased risk of contracting blood-borne viruses (BBV) and injection-related health problems. Needle and equipment sharing is still a common occurrence among PWID in Australia, despite high coverage of ...
Agramunt, Seraina   +1 more
core   +1 more source

Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland [PDF]

open access: yes, 2012
Prevalence of the hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland is high. The Scottish Government has invested significantly in harm reduction interventions with the goal of reducing HCV transmission among PWID.
Hutchinson, Sharon   +5 more
core   +4 more sources

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland

open access: yesDrug and Alcohol Dependence Reports, 2023
Background: SARS-CoV-2 serosurveys can help characterize disparities in SARS-CoV-2 infection and identify gaps in population immunity. Data on SARS-CoV-2 seroprevalence among people who inject drugs (PWID) are limited.
Eshan U. Patel   +9 more
doaj   +1 more source

Prevalence and duration of periods of incarceration experienced by people who inject drugs

open access: yes, 2020
Our aim is to determine the prevalence of incarceration among people who inject drugs, and the length of incarceration periods experienced by people who inject ...
Javier Cepeda   +5 more
core   +9 more sources

COVID-19 vaccine deliberation among people who inject drugs

open access: yesDrug and Alcohol Dependence Reports, 2022
Background: People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration.
Camille C Cioffi   +5 more
doaj   +1 more source

Income generating activities of people who inject drugs [PDF]

open access: yesDrug and Alcohol Dependence, 2007
Background Injection drug users (IDU) commonly generate income through prohibited activities, such as drug dealing and sex trade work, which carry significant risk. However, little is known about the IDU who engage in such activities and the role of active drug use in perpetuating this behavior.
DeBeck, Kora   +5 more
openaire   +3 more sources

Hepatitis B vaccination for people who inject drugs

open access: yesThe Lancet, 2015
Tim Weaver and colleagues’ Article is the fourth randomised controlled trial to show that contingency management can increase hepatitis B vaccination completion in people who inject drugs. Although the completion rates reported in the study by Weaver and colleagues (9%, 45%, and 49%) are consistent with previous observational research, which has ...
Vivian D, Hope   +4 more
openaire   +5 more sources

Estimating the population size of people who inject drugs in Canada, 2021. [PDF]

open access: yesCan Commun Dis Rep
BACKGROUND: People who inject drugs are disproportionately affected by HIV and hepatitis C infections. Estimating the size and distribution of this population is essential in monitoring infectious diseases rates and progress towards elimination ...
Williams A   +7 more
europepmc   +2 more sources

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework

open access: yesJournal of Virus Eradication, 2018
The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030.
Ste.phanie Popping   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy